The afternoon session will cover:
- Gaining an understanding of the biological aspects of ADCs
- Selecting the most appropriate ADC target
- Choosing an optimum antibody format
- Analysing the choices and trade-offs in utilising the chemistry ADC toolbox
- Assessing key factors in the evaluation of efficacy information from in vivo preclinical models